Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|January 15, 2013
NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responsesAlessandra Zingoni, Michele Ardolino, Angela Santoni, et al.
Blood|January 7, 2009
Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cellsCristina Cerboni, Michele Ardolino, Angela Santoni, et al.
Journal of Leukocyte Biology|February 28, 2019
Senescent cells: Living or dying is a matter of NK cellsFabrizio Antonangeli, Alessandra Zingoni, Alessandra Soriani, et al.
Frontiers in Immunology|November 19, 2019
Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic InterventionRosa Molfetta, Alessandra Zingoni, Angela Santoni, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|August 8, 2007
Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cellsAngela Santoni, Alessandra Zingoni, Cristina Cerboni, et al.
Frontiers in Immunology|April 10, 2020
NKG2D Ligand Shedding in Response to Stress: Role of ADAM10Alessandra Zingoni, Elisabetta Vulpis, Luisa Loconte, et al.
International Journal of Molecular Sciences|February 3, 2019
Cancer Exosomes as Conveyors of Stress-Induced Molecules: New Players in the Modulation of NK Cell ResponseElisabetta Vulpis, Alessandra Soriani, Cristina Cerboni, et al.
Cytokine & Growth Factor Reviews|December 16, 2019
Cancer extracellular vesicles as novel regulators of NK cell responseAlessandra Soriani, Elisabetta Vulpis, Lorenzo Cuollo, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|February 1, 2020
Impact of the protein corona on nanomaterial immune response and targeting abilityLuca Digiacomo, Daniela Pozzi, Sara Palchetti, et al.
Biomed Research International|July 11, 2015
NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple MyelomaCinzia Fionda, Alessandra Soriani, Alessandra Zingoni, et al.
Pageof 8